|
|
 |
|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS |
|
|
|
|
|
|
Tumor Board Reviewing the Use of PSMA PET in Prostate Cancer - Gleason 4+4=8 GG 4, 12 of 12 Cores, High Risk Localized Disease
|
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| In this Clinical Case-Based Learning Educational Program, a Virtual Tumor Board in Prostate Cancer presents the case of a 62-year-old man with a history of hypertension.
|
|
|
|
|
|
|
|
|
|
|
|
| Tumor Board Reviewing the Use of PSMA PET in the Care of Patient with Gleason 3+4=7 GG 2, 3 Cores on Right, 6 Negative Cores Prostate Adenocarcinoma |
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| This Clinical Case-Based Learning Educational Program, Virtual Tumor Board in Prostate Cancer presents the case of a 69-year-old man with a history of Crohn's disease that's under control, arthritis, chronic HCV, hypertension, and NMIBC.
|
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Board Reviewing the Use of PSMA PET in Patient with Gleason 3+4=7 with MLH1 Pathogenic Mutation Prostate Adenocarcinoma
|
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| This Clinical Case-Based Learning Educational Program, Virtual Tumor Board in Prostate Cancer presents the case of a 66 year old man with a history of hypertension and hypercholesterolemia. |
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Board Reviewing the Use of PSMA PET in Prostate Cancer - Gleason 3+3=6 GG 1, PALB2 Mutation
|
|
Alicia Morgans, MD, MPH, Heather Jacene, MD, Paul Nguyen, MD, and Adam Kibel, MD
|
| This Clinical Case-Based Learning Educational Program, Virtual Tumor Board in Prostate Cancer, a case of a 63-year-old man with no significant past medical history is presented. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
